Aspire Biopharma Holdings has completed its acquisition of Dura Driver Control Systems (DCS), a tier-one automotive supplier, for approximately $30 million in cash. The DCS acquisition adds a global business with more than $200 million in 2025 revenue, making the supplier a wholly owned subsidiary as Aspire pursues diversification into automotive. Aspire funded the deal with a new $22.5 million secured revolving credit facility and cash on hand. DCS, which has more than a century of history, supplies driver control systems supporting vehicle electrification, safety and lightweighting. The supplier operates 11 manufacturing sites across North America, Europe and Asia and serves more than 50 OEM customers. For the 12 months ended December 2025, DCS reported revenue of approximately $209.5 million and Adjusted EBITDA of $22.3 million. In the six months to June 2026, it generated revenue of approximately $103.9 million and Adjusted EBITDA of $10.5 million. DCS chief executive Hans Vorstenbosch will continue leading the subsidiary, supported by the existing management team under Gregory Corona, chairman of Lakewood & Company. In a statement, Kraig Higginson, chief executive and chairperson of Aspire’s board, said: ‘Closing the DCS acquisition is a cash-flow-positive milestone that structurally enhances Aspire’s valuation.’ Higginson added that DCS’s 2025 performance immediately elevates Aspire to enterprise scale and strengthens its capital flexibility. Source: Aspire Biopharma